Showing results (141-150 of 360) with videos related to

Sort By:
Pageof 36
Urology|March 18, 2003
Assessment of surgical technique and perioperative morbidity associated with extraperitoneal versus transperitoneal laparoscopic radical prostatectomyAndrs Hoznek, Patrick Antiphon, Tomasz Borkowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cellsAlexandre de la Taille, Mark A Rubin, Min-Wei Chen, et al.
Urologic Oncology|July 2, 2011
Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer controlEvanguelos Xylinas, Xavier Durand, Guillaume Ploussard, et al.
World Journal of Urology|July 3, 2014
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy coresThomas Seisen, Françoise Roudot-Thoraval, Pierre Olivier Bosset, et al.
BJU International|November 6, 2010
Low pretreatment total testosterone (< 3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancerEvanguelos Xylinas, Guillaume Ploussard, Xavier Durand, et al.
World Journal of Urology|November 26, 2010
Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumorsOlivier Alenda, Guillaume Ploussard, Pascal Mouracade, et al.
BJU International|August 27, 2004
Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancerDimitri Vordos, Bernard Paule, Francis Vacherot, et al.
BJU International|May 27, 2009
Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsyKevin De Laet, Alexandre de la Taille, Guillaume Ploussard, et al.
BJU International|May 12, 2010
The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core numberGuillaume Ploussard, Vidal Azancot, Nathalie Nicolaiew, et al.
International Journal of Molecular Sciences|May 14, 2022
Overexpression of Nucleolin and Associated Genes in Prostate CancerVirginie Firlej, Pascale Soyeux, Maya Nourieh, et al.
Pageof 36